Bio

• 25 years of diverse drug discovery experience in both small and large molecule discovery with demonstrated success as an innovative scientific and business leader. • Significant contributions in advancing multiple molecules into clinical testing for Oncology, ImmunoOncology, Diabetes and Neurodegeneration. • Broad expertise in preclinical drug discovery, pharmacology, applied technologies, and translational research. • Expert at developing and implementing strategies for external innovation and effective collaboration with external investigators. • Extraordinary track record of enhancing R&D effectiveness. • Committed to employee development, philanthropy, and harnessing diversity and inclusion to maximize success for both individuals and the organization.